Next, we investigated the survival associations of these cells in combination with the NK subsets and found that BLCA patients with high CD56bright or CD56dim NK with high CD8+ TEM and mDCs signatures had improved survival (Figures 3B, C). This evidence concerns the gene CD8A and bladder transitional cell carcinoma.